ILARIS’s Breakthrough in Rheumatology: Market Adoption and Future Growth
Understanding Ilaris: A Breakthrough in Treating Autoimmune and Inflammatory Conditions Ilaris (canakinumab) is a groundbreaking biologic medication developed by Novartis, […]